Good Distribution Practices for pharmaceutical products

Maintain quality, efficacy and integrity of your medicinal product with EU Good Distribution Practices (GDP)

Manufacturers of medicinal products have the responsibility to ensure that every step, from production to final distribution is compliant with a set of market, legal and regulatory requirements. The Good Distribution Practices (GDP) for medicinal products are a quality system developed at European level in order to ensure that storage and transport preserve quality, integrity and efficacy of a medicinal product until it reaches the final selling point.

Demonstrate commitment to quality with being GDP compliant

By making sure your processes for storage and transport are compliant with GDP, you demonstrate commitment to quality and ensure:

• Medicines are placed in the right conditions during transportation
• Contamination during transportation by other products is avoided
• Products in the supply chain are compliant with EU legislation
• Stored medicines are replaced following the right turnover time
• Products reach the right place within the right timeline.

Eurofins Healthcare Assurance provides GDP assessments for better European market access